Veticop 20 mg/ml Suspension for Injection

Country: United Kingdom

Language: English

Source: VMD (Veterinary Medicines Directorate)

Active ingredient:

Copper

Available from:

Ballinskelligs Veterinary Products

INN (International Name):

Copper

Pharmaceutical form:

Suspension for injection

Prescription type:

POM-VPS -Prescription Only Medicine – Veterinarian, Pharmacist, Suitably Qualified Person

Therapeutic group:

Sheep

Therapeutic area:

Mineral

Authorization status:

Authorized

Authorization date:

1997-04-02

Summary of Product characteristics

Revised: February 2016
AN: 01242/2015
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Veticop 20mg/ml Suspension for Injection
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each ml contains:
ACTIVE SUBSTANCE:
Copper (as copper methionate) 20mg
EXCIPIENT:
Chlorocresol (as preservative) 1mg
For a full list of excipients, see section 6.1
3.
PHARMACEUTICAL FORM
Suspension for Injection
A sterile blue suspension which upon standing, gradually leaves a
clear
supernatant.
4.
CLINICAL PARTICULARS
4.1.1
TARGET SPECIES
Sheep
4.2
INDICATION FOR USE, SPECIFYING THE TARGET SPECIES
For the prevention and treatment of copper deficiency (hypocuprosis)
in sheep and for the prevention of swayback in lambs by administering
a single injection to the ewe 2.5 months pre-lambing.
4.3 CONTRA-INDICATIONS
Do not administer intravenously of intramuscularly.
Do not overdose as there is no specific antidote.
Do not administer other forms of copper treatment or supplementation
concurrently.
Revised: February 2016
AN: 01242/2015
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES.
The copper status on farms may change from year to year: it is
therefore recommended that random samples of serum are periodically
checked to see if the deficiency still exists, as sheep are sensitive
to
copper toxicity.
4.5
SPECIAL PRECAUTION FOR USE
Special precautions for use in animals
Shake the vial vigorously prior to use.
Special
precautions
to
be
taken
by
the
person
administering
the
product to animals
None
4.6
ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS)
Some local reactions occur occasionally. These usually subside in
time.
4.7
USE DURING PREGNANCY, LACTATION OR LAY
Safe for use during pregnancy and lactation.
4.8
INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF
INTERACTION
Do
not
administer
with
other
forms
of
copper
treatment
or
supplementation.
4.9
AMOUNTS TO BE ADMINISTERED AND ADMINISTRATION ROUTE
The need for therapy should be assessed on serum and liver analysis
before treatment. Inject into a clean site subcutaneou